Published in Crit Care Med on April 01, 2011
Paracetamol Study in Patients With Low Muscle Mass | NCT03648658
Paracetamol: a focus for the general pediatrician. Eur J Pediatr (2013) 0.87
Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases. Am J Ther (2014) 0.82
[Paracetamol. Efficacious and safe for all ages]. Schmerz (2013) 0.80
A review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdose. Open Access Emerg Med (2011) 0.75
Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol (1993) 7.63
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49
Acetaminophen-induced hepatotoxicity. Drug Metab Dispos (2003) 3.22
Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci (2005) 3.12
N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A (1984) 3.09
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol (1993) 2.89
Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54
Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos (2002) 2.34
Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure. Drug Metab Dispos (2009) 1.95
Medication-induced mitochondrial damage and disease. Mol Nutr Food Res (2008) 1.68
Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol (1993) 1.67
Acetaminophen-associated hepatic injury: evaluation of acetaminophen protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther (2008) 1.48
Propofol infusion syndrome: update of clinical manifestation and pathophysiology. Minerva Anestesiol (2009) 1.27
Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol (2005) 1.24
Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice. Exp Toxicol Pathol (2007) 1.12
Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day. Med J Aust (1999) 1.11
Acetaminophen-induced hepatotoxicity. Life Sci (1981) 1.09
FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA (2009) 1.04
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides. J Pharmacol Exp Ther (1989) 1.00
Evaluation of methodology for nutritional assessment in children: anthropometry, body composition, and energy expenditure. Annu Rev Nutr (1997) 0.96
Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J Neurol (2009) 0.96
Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes. Toxicol Sci (2005) 0.94
Drug-induced liver injury: what was new in 2008? Expert Opin Drug Metab Toxicol (2009) 0.92
Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther (2010) 0.87
Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury. Clin Gastroenterol Hepatol (2009) 0.87
Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia (2008) 0.84
Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats. Toxicology (2002) 0.83
Diets with corn oil and/or low protein increase acute acetaminophen hepatotoxicity compared to diets with beef tallow in a rat model. Nutr Res Pract (2009) 0.80
Effects of thiamine deficiency on hepatic cytochromes P450 and drug-metabolizing enzyme activities. Biochem Pharmacol (1990) 0.77
Nutritional assessment in children and adolescents. Curr Opin Pediatr (1997) 0.77
Prevalence of depression during pregnancy: systematic review. Obstet Gynecol (2004) 5.42
Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology (2006) 3.85
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71
Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol (2013) 3.68
Do we still hurt newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch Pediatr Adolesc Med (2003) 2.94
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia. J Pediatr (2011) 2.86
Variables associated with medication errors in pediatric emergency medicine. Pediatrics (2002) 2.86
Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can (2007) 2.64
Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology (2011) 2.61
Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol (2010) 2.54
Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther (2002) 2.53
Perinatal risks of untreated depression during pregnancy. Can J Psychiatry (2004) 2.50
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metab Dispos (2002) 2.34
Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med (2002) 2.32
Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes. Am J Obstet Gynecol (2012) 2.23
Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry (2008) 2.22
Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol (2008) 2.06
The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG (2004) 2.04
The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol (2009) 2.03
FDA pregnancy risk categories and the CPS: do they help or are they a hindrance? Can Fam Physician (2010) 2.02
Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry (2008) 2.01
Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry (2005) 2.00
Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. CMAJ (2005) 1.99
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin Ther (2007) 1.98
Prematurity, Opioid Exposure and Neonatal Pain: Do They Affect the Developing Brain? Neonatology (2015) 1.96
Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93
Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther (2003) 1.91
Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit (2003) 1.91
Measurement of cortisol in human hair as a biomarker of systemic exposure. Clin Invest Med (2007) 1.91
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89
Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry (2012) 1.88
Persistent low microcirculatory vessel density in nonsurvivors of sepsis in pediatric intensive care. Crit Care Med (2011) 1.87
Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician (2007) 1.83
Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril (2006) 1.80
The use of the Behavioral Pain Scale to assess pain in conscious sedated patients. Anesth Analg (2009) 1.79
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells (2008) 1.78
Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions. Psychoneuroendocrinology (2011) 1.78
Child neurodevelopmental outcome and maternal occupational exposure to solvents. Arch Pediatr Adolesc Med (2004) 1.77
Assessment of sedation levels in pediatric intensive care patients can be improved by using the COMFORT "behavior" scale. Pediatr Crit Care Med (2005) 1.76
Rates of spontaneous and therapeutic abortions following use of antidepressants in pregnancy: results from a large prospective database. J Obstet Gynaecol Can (2009) 1.76
Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation. Crit Care Med (2008) 1.74
Universal critical dynamics in high resolution neuronal avalanche data. Phys Rev Lett (2012) 1.73
Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol (2009) 1.72
Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol (2007) 1.70
Dysphagia in children with severe generalized cerebral palsy and intellectual disability. Dev Med Child Neurol (2008) 1.70
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry (2002) 1.68
Effect of chemical stabilizers of hypoxia-inducible factors on early lung development. Am J Physiol Lung Cell Mol Physiol (2007) 1.68
Historical perspective: the original description of fetal alcohol spectrum disorder in France, 1967. Ther Drug Monit (2003) 1.68
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.67
The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry (2013) 1.66
Routine morphine infusion in preterm newborns who received ventilatory support: a randomized controlled trial. JAMA (2003) 1.66
Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65
Pregnancy outcome following non-obstetric surgical intervention. Am J Surg (2005) 1.65
Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg (2009) 1.65
Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev (2004) 1.65
Paracetamol and metabolite pharmacokinetics in infants. Eur J Clin Pharmacol (2003) 1.65
More codeine fatalities after tonsillectomy in North American children. Pediatrics (2012) 1.63
Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology (2005) 1.62
Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62
Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60
Pregnancy and isotretinoin therapy. CMAJ (2013) 1.60
Changes in buccal microcirculation following extracorporeal membrane oxygenation in term neonates with severe respiratory failure. Crit Care Med (2009) 1.59
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Saf (2002) 1.58
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel. Cancer Biol Ther (2006) 1.58
Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med (2009) 1.57
Chromosomal anomalies in the aetiology of oesophageal atresia and tracheo-oesophageal fistula. Eur J Med Genet (2007) 1.55
Discrepancies between ordered and delivered concentrations of opiate infusions in critical care. Crit Care Med (2003) 1.55
Hair mercury levels of women of reproductive age in Ontario, Canada: implications to fetal safety and fish consumption. J Pediatr (2010) 1.52
Breast-feeding during maternal use of azathioprine. Ann Pharmacother (2006) 1.52
Long-term neuropsychological outcomes in children and adolescents after cardiac arrest. Intensive Care Med (2015) 1.51
Adequate feeding and the usefulness of the respiratory quotient in critically ill children. Nutrition (2005) 1.51
Spatial correlation of action potential duration and diastolic dysfunction in transgenic and drug-induced LQT2 rabbits. Heart Rhythm (2013) 1.50
A randomized cross over trial of tolerability and compliance of a micronutrient supplement with low iron separated from calcium vs high iron combined with calcium in pregnant women [ISRCTN56071145]. BMC Pregnancy Childbirth (2006) 1.50
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2. Am J Transplant (2005) 1.50
Translational biomarkers of acetaminophen-induced acute liver injury. Arch Toxicol (2015) 1.49
Analgesia-sedation in PICU and neurological outcome: a secondary analysis of long-term neuropsychological follow-up in meningococcal septic shock survivors*. Pediatr Crit Care Med (2014) 1.49
Steam inhalation therapy: severe scalds as an adverse side effect. Br J Gen Pract (2012) 1.48
The effect of critical illness and inflammation on midazolam therapy in children. Pediatr Crit Care Med (2012) 1.48
Illness severity and parental permission for clinical research in a pediatric ICU population. Intensive Care Med (2005) 1.48
Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother (2003) 1.48
Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. Am J Hum Genet (2005) 1.47
Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem (2011) 1.45
Hair methylmercury: a new indication for therapeutic monitoring. Ther Drug Monit (2010) 1.44
Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med (2002) 1.44
Safety of the newer class of opioid antagonists in pregnancy. Can Fam Physician (2014) 1.43
Environmental factors in the etiology of esophageal atresia and congenital diaphragmatic hernia: results of a case-control study. Birth Defects Res A Clin Mol Teratol (2008) 1.43
Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila) (2010) 1.43
Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol (2011) 1.43
Evaluation of drug formularies for pediatric intensive care. Pediatr Crit Care Med (2011) 1.42
Physicians' perceptions of teratogenic risk associated with radiography and CT during early pregnancy. AJR Am J Roentgenol (2004) 1.42